Yunjuan Yang | Public Health | Best Researcher Award

Published on by China Scientist

Prof. Dr. Yunjuan Yang | Public Health | Best Researcher Award 

Yunjuan Yang is a public health researcher at the Yunnan Centers for Disease Control and Prevention, specializing in children and adolescent health. Her work focuses on the mental health impacts of lifestyle factors such as sleep and outdoor activity. She is the recipient of the Yunnan Provincial Grant for Academic Leadership and has published in the Journal of Affective Disorders. With expertise in stress models and adolescent well-being, she is recognized for her contributions to evidence-based public health strategies in China.

Prof. Dr. Yunjuan Yang | Yunnan Academy of Preventive Medicine | China

Profile

🎓Education

  • Yunjuan Yang has built her academic foundation in the field of public health, with a particular focus on the well-being of children and adolescents. Her educational background has equipped her with the knowledge and expertise to address complex health challenges affecting young populations. Through continuous professional development and academic involvement, she has remained aligned with cutting-edge public health practices and methodologies.

👨‍🏫 Experience

  • Yunjuan Yang currently serves at the Yunnan Centers for Disease Control and Prevention, where she contributes to vital research and public health initiatives. With a strong commitment to children and adolescent health, she has actively engaged in research exploring the behavioral and psychological dimensions of youth development. Her role has also included data analysis, program development, and the implementation of evidence-based interventions.

🤝 Awards and Recognition

  • Yunjuan Yang’s research contributions have been acknowledged through a prestigious Yunnan Provincial Grant for Academic Leadership. This award underscores her status as a leading researcher in her field and highlights her ability to lead innovative studies that address pressing public health concerns. She has also been recognized with a Best Researcher Award for her impactful work in adolescent mental health.

💡Skills and Certifications

  • Yunjuan Yang is proficient in public health surveillance, data interpretation, and research methodologies related to child and adolescent well-being. She is skilled in mental health assessment frameworks and is experienced in applying theoretical models such as the Stress Susceptibility-Recovery Model. Her strengths lie in interdisciplinary collaboration, scientific writing, and community health analysis.

🔬 Research Focus

  • Yunjuan Yang’s primary research focus lies in children and adolescent health, with a specialized emphasis on mental health outcomes. Her latest study, published in the Journal of Affective Disorders, examines how sleep duration and daytime outdoor activity influence mental health using a stress-related model. This work contributes to understanding how lifestyle factors affect psychological resilience and vulnerability in adolescents, and it offers evidence to guide public health policy and school-based interventions.

🌎Conclusion

  • Yunjuan Yang is exceptionally suited for the Research for Best Researcher Award. Her impactful publications, leadership recognition, and clear commitment to addressing major public health burdens—both behavioral and chronic—reflect outstanding merit. Her work contributes to global discussions while driving regional health improvements, making her a deserving and forward-looking candidate for this honor.

📖Publications

Title: Short sleep duration and daytime outdoor activities effects on adolescents mental health: A stress susceptibility-recovery model analysis
Authors: Yang X, Yang Y, Yang J, Ni J, Li H, Mu X, Wang C
Journal: Journal of Affective Disorders

Title: Unveiling China’s heart disease challenges: a comprehensive retrospective study on national mortality burden
Authors: Yunjuan Yang, Jieqing Min, Yuanyi Zha
Journal: BMC Public Health

Chunbo Li | Gynecology | Best Researcher Award

Published on by China Scientist

 Dr. Chunbo Li | Gynecology | Best Researcher Award

Research Contributions:

  • Dr. Li has been actively involved in multiple research projects funded by the National Natural Science Foundation of China and other prestigious organizations. These include studies on the effects of PM2.5 exposure during pregnancy, mesenchymal stem cell therapies, and molecular classification of cervical cancer. His leadership as a host in ongoing projects highlights his capabilities as a principal investigator.
Dr. Chunbo Li, Obstetrics and Gynecology Hospital of Fudan University, China

Profile

Scopus

🌱EARLY ACADEMIC PURSUITS

  • Dr. Li Chunbo began his illustrious academic journey at Fudan University, a top institution in China. He earned his Bachelor’s Degree in Clinical Medicine (2007-2012), laying the foundation for his medical expertise. This was followed by a Master’s Degree in Surgery (2012-2015), where he deepened his knowledge in surgical procedures and interventions. Dr. Li then pursued a PhD in Obstetrics and Gynecology (2018-2021), focusing on advanced research in women’s health. His academic background reflects a continuous pursuit of excellence and dedication to advancing medical science.

💼PROFESSIONAL ENDEAVORS

  • Dr. Li Chunbo has extensive professional experience, demonstrating his commitment to patient care and medical innovation. Since 2017, he has been an Attending Physician at the Affiliated Obstetrics and Gynecology Hospital of Fudan University, where he treats complex gynecological cases and contributes to cutting-edge research. Before this, he served as a Physician at the First Maternal and Infant Health Care Hospital of Tongji University from 2015 to 2017. His professional career highlights his dual focus on clinical excellence and academic advancement, benefiting both patients and the scientific community.

🔬CONTRIBUTIONS AND RESEARCH FOCUS 

  • Dr. Li has made remarkable contributions to the field of obstetrics and gynecology through his innovative research. His studies focus on the effects of PM2.5 exposure during pregnancy, examining its impact on mitochondrial imbalances and fetal growth. He has also explored pelvic organ prolapse and the therapeutic role of mesenchymal stem cells in tissue repair and inflammation regulation. In addition, Dr. Li is pioneering research into the molecular subtypes of cervical cancer, with the goal of developing targeted therapies tailored to the Chinese population. His work exemplifies the integration of clinical insight and scientific discovery.

🌍IMPACT AND INFLUENCE

  • Dr. Li Chunbo’s work has had a profound impact on both clinical practices and academic research. He has led significant projects, such as the Shanghai Youth Project, which investigates stem cell-based treatments for endometrial repair. His innovative approach has resulted in five high-impact publications in journals like Molecular Therapy – Nucleic Acids and Communications Biology. Furthermore, his dedication to advancing women’s health was recognized with the Shanghai “Medical Star” Talent Training Program Award in 2019. These achievements underscore his influence as a leader in gynecological and oncology research.

📜 ACADEMIC CITES 

  • Dr. Li’s research has gained widespread recognition within the academic community, as reflected in the numerous citations of his work. His single-cell transcriptomic studies have become key references in understanding the molecular and cellular mechanisms underlying cervical cancer. These contributions have not only enhanced academic discourse but also provided actionable insights for improving diagnosis and treatment strategies in clinical settings.

🧬 LEGACY AND FUTURE CONTRIBUTIONS

  • Dr. Li Chunbo’s legacy lies in his commitment to advancing medical science and improving patient outcomes. His ongoing research into targeted therapies for cervical cancer aims to revolutionize precision medicine in the Chinese population. Additionally, he is fostering collaboration between clinicians and researchers to integrate emerging technologies like single-cell transcriptomics into routine practice. Dr. Li also seeks to mentor the next generation of medical professionals, sharing his expertise to inspire innovation in obstetrics and gynecology. His forward-thinking approach ensures a lasting impact on the field and its future advancements.

📄Publications

  • Corrigendum: Dissecting the single-cell transcriptome network of immune environment underlying cervical premalignant lesion, cervical cancer and metastatic lymph nodes
    • Authors: Li, C.; Hua, K.
    • Journal: Frontiers in Immunology, 2024, 15, 1386072
  • Single-cell transcriptomics provides insights into the origin and immune microenvironment of cervical precancerous lesions
    • Authors: Li, C.; Hua, K.
    • Journal: Cancer Communications, 2023, 43(9), pp. 1055–1058
  • Diverse intratumoral heterogeneity and immune microenvironment of two HPV-related cervical cancer types revealed by single-cell RNA sequencing
    • Authors: Li, C.; Liu, D.; Zhao, Y.; Ding, Y.; Hua, K.
    • Journal: Journal of Medical Virology, 2023, 95(6), e28857
  • Association of preoperative conization with recurrences after laparoscopic radical hysterectomy for FIGO 2018 stage IB1 cervical cancer
    • Authors: Ding, Y.; Zhang, X.; Qiu, J.; Li, C.; Hua, K.
    • Journal: Archives of Gynecology and Obstetrics, 2023, 307(6), pp. 1901–1909
  • Integrated single-cell transcriptome analysis of the tumor ecosystems underlying cervical cancer metastasis
    • Authors: Li, C.; Liu, D.; Yang, S.; Hua, K.
    • Journal: Frontiers in Immunology, 2022, 13, 966291

Yu Kang | Obstetrics and Gynecology | Best Researcher Award

Published on by China Scientist

Prof .Yu Kang | Obstetrics and Gynecology | Best Researcher Award

Innovative Research Projects:
  • Dr. Kang has successfully led and participated in 16 research projects, including collaborations with prestigious institutions like MD Anderson, underscoring his role in advancing cancer treatment methodologies.
Prof. Yu Kang , Obstetrics & Gynecology Hospital of Fudan University, China

Profile

Scopus

🌱EARLY ACADEMIC PURSUITS

  • Dr. Yu Kang obtained his PhD and completed his postdoctoral fellowship at MD Anderson Cancer Research Center, which laid a strong foundation for his research in gynecologic oncology. His early education focused on the mechanisms of cancer biology and treatment modalities, establishing a profound understanding of the complexities of gynecologic tumors.

💼 PROFESSIONAL ENDEAVORS

  • Currently serving as the chief physician at the Obstetrics & Gynecology Hospital of Fudan University, Dr. Kang is also a doctoral supervisor. His clinical practice centers around individualized precision treatment and prevention strategies for gynecologic tumors, ensuring that patients receive the most effective therapies tailored to their specific needs.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS 

  • Dr. Kang’s main research focus includes ovarian cancer, PJ syndrome, and hereditary breast and ovarian cancer (HBOC). He has published extensively in prestigious journals such as JNCI, contributing significantly to the understanding and treatment of rare gynecological tumors. His research has led to the publication of 32 SCI articles, the acquisition of 4 national patents, and the authorship of 12 monographs.

📚 ACADEMIC CITES 

  • While specific citation metrics are not provided, Dr. Kang’s prolific output of 53 journal publications in SCI and Scopus-indexed journals underscores his impact in the academic community and highlights the significance of his research findings in advancing gynecologic cancer treatment.

🌍 Impact and Influence

  • Through his research and clinical practice, Dr. Kang has made significant strides in the field of gynecologic oncology, particularly in precision medicine. His collaborative efforts with organizations such as the MD Anderson Cancer Center Sister Organization Network Foundation have further advanced the potential treatment options for epithelial ovarian cancer, showcasing his commitment to improving patient outcomes.

🌟 Legacy and Future Contributions

  • Dr. Kang’s ongoing work in the field of gynecologic tumors aims to pave the way for innovative treatment modalities and improved patient care. With several patents in process and an active editorial role in Gynecologic Oncology, he is poised to continue influencing the field significantly. His commitment to research and patient care ensures a lasting legacy in gynecologic oncology.

📄Publications

  • MRI grading for informed clinical decision-making in Peutz–Jeghers syndrome patients with cervical lesions
    Authors: Jiang, A., Chen, Y., Ning, Y., Xu, C., Kang, Y.
    Journal: Scientific Reports, 2024, 14(1), 23731
  • Clinical characteristics and status of treatment of small-cell carcinoma of the ovary, hypercalcemic type in the Chinese population: a meta-analysis
    Authors: Zheng, K., Gao, Y., Xu, C., Kang, Y.
    Journal: Journal of Gynecologic Oncology, 2024, 35(4), e96
  • Immunotherapy combined with targeted therapy in advanced small cell carcinoma of the ovary of hypercalcemic type: A case of overall survival lasting for over 5 years
    Authors: Gao, Y., Zang, L., Ye, Y., Wang, H., Xu, C., Kang, Y.
    Journal: European Journal of Obstetrics and Gynecology and Reproductive Biology, 2024, 297, pp. 270–274
  • Correction to: Dominant-negative transforming growth factor-β receptor-armoured mesothelin-targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancer
    Authors: Li, K., Xu, J., Wang, J., Wu, S., Kang, Y.
    Journal: Cancer Immunology, Immunotherapy, 2024, 73(6), 105
  • Do survivors of borderline ovarian tumors have susceptibility to secondary primary malignancies? A SEER population-based study
    Authors: Wang, J., Du, Y., Kang, Y.
    Journal: International Journal of Gynecology and Obstetrics, 2024, 165(3), pp. 1229–1236